pioglitazone has been researched along with Congenital Adrenal Hyperplasia in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess insulin sensitivity in CAH patients and the effect of pioglitazone treatment on insulin sensitivity in CAH patients." | 9.14 | Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia. ( Hermus, AR; Kroese, JM; Mooij, CF; Tack, CJ; van der Graaf, M, 2009) |
| "To assess insulin sensitivity in CAH patients and the effect of pioglitazone treatment on insulin sensitivity in CAH patients." | 5.14 | Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia. ( Hermus, AR; Kroese, JM; Mooij, CF; Tack, CJ; van der Graaf, M, 2009) |
| "After both placebo and pioglitazone treatment, insulin sensitivity was determined by hyperinsulinemic euglycemic clamp and abdominal sc adipose tissue was obtained to measure adipocyte cell surface and expression of genes involved in glucose uptake and inflammation." | 5.14 | Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients. ( de Graaf, J; Hermus, AR; Koenen, TB; Kroese, JM; Stalenhoef, AF; Stienstra, R; Sweep, FC; Tack, CJ; van der Laak, J; van Tits, LJ, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kroese, JM | 2 |
| Mooij, CF | 1 |
| van der Graaf, M | 1 |
| Hermus, AR | 2 |
| Tack, CJ | 2 |
| Koenen, TB | 1 |
| Sweep, FC | 1 |
| van der Laak, J | 1 |
| Stalenhoef, AF | 1 |
| de Graaf, J | 1 |
| van Tits, LJ | 1 |
| Stienstra, R | 1 |
2 trials available for pioglitazone and Congenital Adrenal Hyperplasia
| Article | Year |
|---|---|
Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia.
Topics: Adipose Tissue; Adrenal Hyperplasia, Congenital; Adult; Blood Pressure; Cross-Over Studies; Female; | 2009 |
Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients.
Topics: Adipocytes; Adrenal Hyperplasia, Congenital; Adult; Cross-Over Studies; Glucose Clamp Technique; Hum | 2009 |